There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NexImmune stock.
Is XP stock a buy?
Is XP a buy right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for XP in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" XP stock.
Is oblong stock a buy?
Oblong has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.